Man Group

Man Group’s Myriad Genetics MYGN Stock Holding History

Man Group’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.25M	Buy	278,202 +196,243	+239%	+$1.02M	﹤0.01%	1761
2025 Q4	$504K	Buy	+81,959	New	+$594K	﹤0.01%	1891
2025 Q3	–	Sell	-37,656	Closed	-$200K	–	2377
2025 Q2	$200K	Buy	37,656 +911	+2%	+$5.38K	﹤0.01%	2074
2025 Q1	$326K	Buy	36,745 +8,290	+29%	+$99.6K	﹤0.01%	1910
2024 Q4	$390K	Buy	+28,455	New	+$525K	﹤0.01%	1723
2022 Q3	–	Hold	0	–	-$2.85M	–	2149
2022 Q2	–	Sell	-272,049	Closed	-$5.65M	–	1000
2022 Q1	$6.86M	Buy	272,049 +33,569	+14%	+$859K	0.02%	762
2021 Q4	$6.58M	Buy	238,480 +105,380	+79%	+$3.05M	0.02%	773
2021 Q3	$4.3M	Buy	133,100 +62,000	+87%	+$2.06M	0.02%	892
2021 Q2	$2.17M	Buy	+71,100	New	+$2.05M	0.01%	1203
2020 Q1	–	Sell	-80,022	Closed	-$2.18M	–	1783
2019 Q4	$2.18M	Sell	80,022 -170,699	-68%	-$4.7M	0.01%	1307
2019 Q3	$7.18M	Buy	+250,721	New	+$7.31M	0.03%	716
2018 Q4	–	Sell	-132,272	Closed	-$6.08M	–	2049
2018 Q3	$6.08M	Buy	132,272 +47,200	+55%	+$2.1M	0.02%	882
2018 Q2	$3.18M	Buy	85,072 +2,015	+2%	+$68.1K	0.01%	1164
2018 Q1	$2.45M	Buy	+83,057	New	+$2.81M	0.01%	1203

Other funds holding MYGN

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return